Request ID: 4682af00-97dd-4f77-b107-8318a7b31d0e Research cutoff: 30 September 2026 Target: AHAVA Dead Sea Laboratories Ltd. Scope: Target, identified parent and named leadership; historical relationships are distinguished from current evidence.
“no public evidence identified” denotes the outcome of bounded public-source research, not an assertion that an activity never occurred. Undated webpages are described as accessible at the research cutoff; this does not independently verify their underlying operational claims.
Corporate Communications & Public Stance
Statements
2017 [pre-2020]; historical statement, subsequently repeated position documented. On 26–27 October 2017, The Jerusalem Post attributed the following statement to Ahava CEO Ron Michael: “I am certain that we are not breaking any international law.” The accessible page supplies this quotation, but not the full underlying interview.1
2025–2026; current dispute. AFSC reproduces Ahava’s response to its 2025 UN listing: the company says its entire production chain has been at Ein Gedi since 2022 and denies ever extracting resources from occupied territory. The OHCHR-hosted original response was not successfully retrieved; this account is therefore attributed to AFSC’s reproduction.2
2026; current response. In reporting published on 5 June 2026, Ahava challenged its UN classification, said it had provided clarification to the relevant UN bodies and was working to rectify the classification.3
Comparative Silence
2022; documented parent communication. Fosun announced a HK$10 million COVID-material donation for Hong Kong on 25 February 2022, including an initial shipment of 250,000 rapid-test kits. Its release identifies civilian recipients including the Hong Kong Anti-Cancer Society, Hong Kong Paediatric Society, Boys’ & Girls’ Clubs Association of Hong Kong and Haven of Hope Christian Service.4
Ukraine, BLM and Palestinian civilian harm: no public evidence identified sufficient to establish a systematic comparative-silence finding. No comprehensive official/social-media archive was obtained.
Market Framing
2016 [pre-2020]; historical transaction framing. Fosun’s acquisition announcement combines commercial expansion with China–Israel economic cooperation and the phrase “Love from Israel.” The release identifies an agreement for 100% of Ahava at NIS290 million and plans to expand the brand internationally.5
2022; subsequent commercial framing. Fosun’s factory-opening release presents Ahava within its global consumer-business strategy and discusses collaboration with Club Med and expansion of Israeli brands.6
Undated, accessible September 2026; current published positioning. Ahava’s FAQ describes facilities on the Dead Sea shores, international university collaborations and environmentally responsible extraction. It does not precisely identify the extraction location or establish the current licence boundaries.7
Operations in Occupied or Contested Territories
Territorial Presence
2012 [pre-2020]; historical evidence, current status disputed. Who Profits’ April 2012 report identifies Ahava’s factory and visitor centre in Mitzpe Shalem in the occupied West Bank and reports extraction of mud from occupied territory. Its historical account also identifies settlement shareholders. These findings are not treated as proof that the same ownership or production arrangements remain unchanged.8
2016 [pre-2020]; historical licence qualification. Who Profits’ November 2016 report recounts earlier Civil Administration confirmation of a mud-excavation licence and an active site. It also records that an April 2016 response said Ahava no longer held that licence. The original correspondence was not independently retrieved; continued possession of that historical licence is not asserted.9
2022; factory opening confirmed, complete withdrawal not independently established. Fosun records Guo Guangchang’s attendance at the opening of Ahava’s new Dead Sea factory on 30 August 2022. That release does not itself resolve every activity at the former site.6
2026; disputed continuing activity. Anadolu Agency describes AFSC photographs from Mitzpe Shalem showing chemical containers carrying 2025/2026 dates and large piles of earth that researchers believed might be Dead Sea mud. Ahava denied operating a production facility there, and chief executive Ron Michael said production had been consolidated within internationally recognised Israeli territory by 2022.3
2024; retail lead, present status unconfirmed. CJPME’s May 2024 fact sheet identifies an Ahava shop at Neve Midbar Beach, citing a March 2023 Who Profits profile. The underlying profile was not successfully retrieved, and the outlet’s September 2026 status remains unconfirmed.10
Legal & Regulatory Scrutiny
2025–2026; reported UN listing. Anadolu Agency reports that Ahava and Fosun were added to the OHCHR settlement-business database in September 2025. This audit does not infer any additional activity classification from that secondary report.3
2014 [pre-2020]; completed court proceeding. In Richardson v DPP, [2014] UKSC 8, decided 5 February 2014, the UK Supreme Court dismissed protesters’ appeals arising from aggravated trespass at the Ahava shop. The judgment addresses the alleged unlawfulness of the activity disrupted and the evidential/legal requirements of the offence. It is not a comprehensive ruling on all international-law allegations concerning Ahava.11
Specific OECD complaint, current regulatory penalty or current product-origin adjudication: no public evidence identified in the retrieved records.
Civil Society & Boycott Campaign History
2009–2014 [pre-2020]; documented historical campaign. CODEPINK’s 28 October 2014 announcement identifies its Stolen Beauty campaign as operating since 2009. It states that settlement manufacturing, resource extraction and labelling were its grounds and reports that GILT removed Ahava products. This is the campaign organiser’s account; the underlying retailer correspondence was not independently retrieved.12
2024; later campaign documentation. CJPME published a fact sheet advocating an Ahava boycott on settlement-operation and resource-extraction grounds.10
2026; documented retailer response. Anadolu Agency reports that Superdrug removed marketplace listings and blocked future Ahava listings after concerns were raised about the settlement-site evidence; products had been supplied through a third-party seller.3
2016 [pre-2020]; counter-position, current endorsement unknown. NGO Monitor disputed Who Profits’ extraction allegation in its report on the organisation and described its role in boycott campaigns. This is an attributed counter-source, not independent resolution of the extraction dispute.13
Internal Governance, Content & Retail Policies
Employee Relations
Through September 2026: no public evidence identified of Ahava-specific dismissal, disciplinary action, union litigation or political-symbol restrictions concerning pro-Palestinian speech.
Parent/group and named principals: no public evidence identified sufficient to attribute such conduct to Ahava through Fosun. Comprehensive employment-litigation searches and internal policies were not obtained.
Platform & Editorial Policy
Through September 2026: no public evidence identified of target-specific algorithmic moderation, conflict-related content suppression or editorial enforcement.
Shareholder-resolution suppression concerning Israel–Palestine: no public evidence identified.
Retail & Supply Chain Practices
2012–2016 [pre-2020]; historical allegations, present label status unconfirmed. Who Profits’ 2016 report objects to “The Dead Sea, Israel” labelling for products it associates with settlement production. This is the NGO’s allegation; it does not establish a current regulator finding against every Ahava product.9
2012 [pre-2020]; official regulatory context, current enforcement unknown. South Africa’s Department of Trade and Industry explained on 25 May 2012 that goods from occupied Palestinian territory should not be incorrectly described as originating in Israel. The retrieved statement sets out the policy and Consumer Protection Act rationale; it is not an Ahava-specific conviction or penalty.14
Undated, accessible September 2026; current published account. Ahava’s FAQ says its extraction is environmentally responsible and claims exclusive rights to extract minerals from Dead Sea water. The page supplies no licence document, geographical coordinates or independent origin verification.7
Brand Heritage & State Partnerships
Marketing Positioning
1988–1989 origins [pre-2020]; heritage retained in later disclosures. Ahava-issued leadership announcements describe a cosmetics business founded in 1988, while its current FAQ identifies Osmoter as patented in 1989 and emphasises mineral skincare and scientific research. No public evidence identified of military or intelligence-service origins used in the retrieved branding.15, 16, 7
Institutional Ties & Sponsorships
2016 [pre-2020]; historical official attendance. Fosun’s acquisition release names Israeli Ministry of Economy and Industry officials Amit Lang and Yariv Becher among witnesses to the transaction signing. Their attendance is documented; a non-commercial political sponsorship agreement is not.5
2022; documented official contacts. Fosun records Guo Guangchang’s meetings with Chinese Ambassador Cai Run, Israeli Tourism Minister Yoel Razvozov and Finance Ministry Chief Economist Shira Greenberg during his factory-opening visit. The release describes economic cooperation, tourism and investment.6
2010–2015 [pre-2020]; historical academic collaboration. Ahava’s 5 May 2026 retrospective describes a five-year collaboration beginning in 2010 with Hebrew University concerning concentrated Osmoter and skin ageing. Renewal of that particular collaboration is not established.17
2024–2027; programme ongoing within its published term. CORDIS identifies Ahava as a participant in SSbD4CheM, grant 101138475, with EUR507,000 in net EU contribution. The programme runs from 1 January 2024 to 31 December 2027 and addresses safer chemicals and materials, including cosmetics.18
December 2025; subsequent participation confirmed. The project’s April 2026 workshop report names Ahava personnel Assaf Assis, David Barak and Dror Cohen assisting a cosmetics case study with the Slovenian National Institute of Chemistry.19
State honours, military sponsorships or formal participation in a “Brand Israel” campaign: no public evidence identified. The documented research activities are not presented as proof of geopolitical advocacy.
Lobbying, Advocacy, Financing & Logistics
Political Lobbying
2013 [pre-2020]; historical commercial-government engagement. A Fosun Pharma release dated 18 June 2013 reproduces an account of Guo Guangchang’s 10 June meeting with Prime Minister Benjamin Netanyahu. It discusses a venture-capital fund, technology investment and commercial cooperation. The meeting predates Fosun’s Ahava acquisition.20
2022; later commercial-government engagement. The official contacts described in Section 4 concern investment and economic cooperation. The retrieved release does not establish registered lobbying or advocacy about boycotts or military policy.6
Ahava/Fosun PAC contributions, regional-policy lobbying, anti-BDS legislative activity or leadership in CFI/AIPAC/ADL/USISTF: no public evidence identified sufficient for attribution. Complete lobbying and campaign-finance database exports were not obtained.
Financial Contributions
Undated, accessible September 2026; current published charity description. Ahava’s social-responsibility page describes a charity committee supporting women’s empowerment through money and resources. It does not name the organisations, amounts or grant dates. Recipient identity and possible conflict-related affiliations remain unresolved.21
2022; named civilian parent-foundation support. Fosun’s Hong Kong COVID announcement identifies material donations and civilian beneficiaries. It is not evidence of IDF, settlement or military-welfare funding.4
October–November 2023; in-kind military-unit support. Ahava’s 8 November 2023 Hebrew corporate statement says it reached combat areas and supplied essential products to Givati’s Shaked Battalion, IDF Division 99 and an unnamed paratrooper battalion. ICE reported the same three military recipients on 25 October 2023 and described skincare donations. The retrieved sources do not disclose quantities, monetary value, procurement terms or a defence contract, and this audit did not identify evidence establishing continuation after 2023.22, 23
FIDF, JNF/KKL, Lev Echad, reservist funds, Regavim, Im Tirtzu or named settlement-organisation donations: no public evidence identified for Ahava or the researched principals in the reviewed record. Historical settlement-linked ownership/operations and disputed current settlement activity are addressed separately below.
Crisis Asset Mobilization
2020–2022; documented pandemic logistics. Fosun’s February 2022 release reports medical-supply deployments across more than 30 countries since the pandemic began, alongside its Hong Kong shipment.4
2023 conflict-related product mobilization. The contemporaneous Ahava and ICE records document in-kind skincare/essential-product support to the three named military formations above. They do not establish quantities, value, purchasing terms, a procurement award or continuation after 2023.22, 23
State-directed crisis infrastructure or reservist salary subsidies: no public evidence identified in the reviewed record.
Settlement Nexus
Historical settlement-linked ownership [pre-2020]; disposal documented. Fosun’s 2016 announcement lists Kibbutz Mitzpe Shalem and Kibbutz Kalia among shareholders whose interests it agreed to acquire. Fosun’s 2022 release confirms a completed wholly owned acquisition. This distinguishes historical settlement equity from present ownership evidence.5, 6
Settlement-event sponsorship, political endorsement of settlement expansion or donations to settlement bodies: no public evidence identified. The disputed operational presence in Section 2 is recorded separately.
Corporate Structure & Primary Mission
Ownership and Control
2016 [pre-2020], confirmed retrospectively in 2022; latest retrieved acquisition confirmation. Fosun announced the purchase of 100% of Ahava and subsequently described the transaction as completed. The historical seller list includes Gaon Holdings, the Livnat family, Shamrock Israel Growth Fund Advisors and settlement kibbutzim. A current complete intermediate corporate chain and shareholder-register extract were not obtained.5, 6
2025–2026; parent leadership. Fosun’s management page identifies Guo Guangchang as chairman, Wang Qunbin as co-chairman, and Chen Qiyu and Xu Xiaoliang as co-CEOs. Several biographies expressly describe positions as at December 2025. These roles do not, by themselves, establish current beneficial ownership percentages.24
Foundational Mandate
Historical founding and current published commercial identity. Ahava’s corporate announcements identify a mineral-skincare enterprise founded in 1988. CORDIS classifies its participant as a private for-profit entity.15, 16, 18
Charter obligation to advance state geopolitical goals, state-held golden share or legally mandated security mission: no public evidence identified. The company’s full charter and current shareholder register were not obtained.
Executive & Leadership Footprint
Identified Leadership and Historical Officeholders
2013 [pre-2020]; historical appointment, later continuation unknown. Ahava announced on 31 July 2013 that Elana Drell Szyfer would replace Yacov Ellis as global CEO effective 1 September 2013.15
2015 [pre-2020]; historical board appointment, current seat unconfirmed. Ahava announced Beth Ann Catalano’s board appointment on 19 February 2015 and identified Ron Michael as worldwide CEO. The release also describes Catalano’s association with the Bobby Buecker Memorial Foundation, supporting families of children with cancer; it supplies no conflict-related grant evidence.16
June 2026; later CEO identification. Anadolu Agency identifies Ron Michael as Ahava’s chief executive.3
2025–2026; parent officeholders. The leadership roles of Guo Guangchang, Wang Qunbin, Chen Qiyu and Xu Xiaoliang are described in Section 6. The management page also records Chinese public/institutional positions for some executives, including Chen’s Shanghai CPPCC role and Xu’s Shanghai Municipal People’s Congress role. These are not evidence of regional advocacy affiliations.24
Personal Philanthropy & Financing
Through September 2026: no public evidence identified of verified personal military-welfare or settlement grants by the researched Ahava leaders or Fosun principals.
Personal/family-office investments in Israeli defence, surveillance or cyber enterprises: no public evidence identified sufficient to identify a qualifying investment, beneficiary and current ownership relationship.
No public evidence identified sufficient to resolve the incomplete foundation-return, family-office-disclosure and donor-record coverage.
Public Advocacy & Statements
2017 [pre-2020]; legal-compliance position. Ron Michael’s quoted denial of illegality is recorded in Section 1.1
2013 [pre-2020] and 2022; commercial diplomacy. Guo Guangchang’s meetings with Netanyahu and later Israeli officials are documented in parent disclosures. The records establish engagement over investment and economic cooperation, not endorsement of specific military operations.20, 6
Explicit public co-belligerency statement, military fundraising appeal, settlement endorsement or attributable pro-/anti-Palestinian signed letter: no public evidence identified.
Board Memberships & Affiliations
2015 [pre-2020]; historical affiliations. The Ahava announcement describes Catalano’s GCI Magazine advisory role and cancer-family philanthropy. Her continuing Ahava board membership is unconfirmed.16
2025–2026; parent affiliations. Fosun’s management biographies disclose group-company and Chinese institutional roles. No public evidence identified sufficient to establish a named principal’s current leadership position in the regional advocacy organisations specified for this audit.24
Evidence After the Requested Notice Dates
After 19 July 2024 and November 2024: The retrieved record includes December 2025 research-project participation and Ahava’s June 2026 public response on the settlement-site dispute. These establish dated subsequent activity, without establishing a change in military or settlement financing.19, 3
2025–2026: The company’s dispute with the UN classification and the contested production-location account are documented in Sections 1–2.2, 3
After 19 July 2024 and November 2024: no public evidence identified establishing continuation or escalation of the documented 2023 military-unit product donations, or verified later suppression, state-directed military logistics or settlement political sponsorship.
Footnotes
-
The Jerusalem Post, Tovah Lazaroff, “Companies on UNHRC settler blacklist: We’re doing nothing wrong,” 26 October 2017, updated 27 October 2017. https://www.jpost.com/israel-news/companies-targeted-by-unhrc-settler-blacklist-reject-wrongdoing-charges-508574 ↩ ↩2
-
AFSC Investigate, “Fosun International Ltd,” undated live profile, accessed 30 September 2026. https://investigate.afsc.org/company/fosun-international ↩ ↩2
-
Anadolu Agency, “UK retailer Superdrug drops Ahava products after reports of activity at Israel’s illegal settlements in West Bank,” 5 June 2026. https://www.aa.com.tr/en/europe/uk-retailer-superdrug-drops-ahava-products-after-reports-of-activity-at-israels-illegal-settlements-in-west-bank/3957371 ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7
-
Fosun, “Fosun Foundation’s First Batch of 250,000 Sets of COVID-19 Rapid Antigen Test Kits Arrives in Hong Kong,” 25 February 2022. https://en.fosun.com/content/details46_4508.html ↩ ↩2 ↩3
-
Fosun, “Fosun Acquires Entire Stake in Israel’s Dead Sea Mineral Skincare Brand AHAVA,” 12 April 2016. https://en.fosun.com/content/details46_4293.html ↩ ↩2 ↩3 ↩4
-
Fosun, “Guo Guangchang, Chairman of Fosun International Meets Cai Run, Chinese Ambassador to Israel in Tel Aviv, Israel and Attends the Opening of AHAVA’s New Factory,” 31 August 2022. https://en.fosun.com/content/details46_4611.html ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7
-
AHAVA, “FAQs,” undated, accessed 30 September 2026. https://global.ahava.com/pages/faqs ↩ ↩2 ↩3
-
Who Profits, “Ahava: Tracking the Trade Trail of Settlement Products,” April 2012. https://www.whoprofits.org/publications/report/60 ↩
-
Who Profits, “The Israeli Exploitation of Palestinian Natural Resources: Part IV,” November 2016. https://www.whoprofits.org/publications/report/132 ↩ ↩2
-
CJPME, “Boycott Campaign: Ahava Dead Sea Laboratories Ltd.,” May 2024. https://www.cjpme.org/fs_243 ↩ ↩2
-
UK Supreme Court, Richardson and another v Director of Public Prosecutions, [2014] UKSC 8, judgment of 5 February 2014. https://supremecourt.uk/uploads/uksc_2012_0198_judgment_8a1cb358f8.pdf ↩
-
CODEPINK, “GILT drops Ahava cosmetics,” 28 October 2014. https://www.codepink.org/online_shopping_site_gilt ↩
-
NGO Monitor, “‘Who Profits’ - Spearheading Global BDS,” 2016; counter-source. https://ngo-monitor.org/reports/who-profits-spearheading-global-bds/ ↩
-
South African Government, Department of Trade and Industry, “Wrongful labelling of products undermines the laws that seek to protect our people and our trading policy,” 25 May 2012. https://www.gov.za/news/media-statements/%E2%80%9Cwrongful-labelling-products-undermines-laws-seek-protect-our-people-and-our ↩
-
AHAVA via PRNewswire, “Elana Drell Szyfer Appointed Chief Executive Officer of AHAVA Worldwide,” 31 July 2013. https://www.prnewswire.com/news-releases/elana-drell-szyfer-appointed-chief-executive-officer-of-ahava-worldwide-217745451.html ↩ ↩2 ↩3
-
AHAVA North America via PRNewswire, “President of AHAVA North America Joins Board of Directors,” 19 February 2015. https://www.prnewswire.com/news-releases/president-of-ahava-north-america-joins-board-of-directors-300038357.html ↩ ↩2 ↩3 ↩4
-
AHAVA, Emily Williams, “The Beautiful Science Behind Osmoter™,” 5 May 2026. https://www.ahava.com/blogs/news/the-beautiful-science-behind-osmoter%E2%84%A2 ↩
-
European Commission CORDIS, “Safe and Sustainable by Design framework for the next generation of Chemicals and Materials,” SSbD4CheM, grant 101138475, 2024–2027. https://cordis.europa.eu/project/id/101138475 ↩ ↩2
-
SSbD4CheM, “Recap of the 2nd NSC workshop on ‘SSbD scenarios’ on 5 December 2025,” 13 April 2026. https://www.ssbd4chem.eu/recap-of-the-2nd-nsc-workshop-on-ssbd-scenarios-on-5-december-2025/ ↩ ↩2
-
Fosun Pharma, “PM Netanyahu Meets with the Chairman of China’s Fosun Group,” 18 June 2013. https://www.fosunpharma.com/en/content/details37_11050.html?20250519=ZCQXB.scm ↩ ↩2
-
AHAVA, “Social Responsibility,” undated, accessed 30 September 2026. https://global.ahava.com/pages/social-responsibility ↩
-
AHAVA Israel, “לתת המון AHAVA לישראל,” 8 November 2023. Hebrew corporate statement; English descriptions in this audit are translations. https://www.ahava.co.il/blogs/news/%D7%9C%D7%AA%D7%AA-%D7%94%D7%9E%D7%95%D7%9F-ahava-%D7%9C%D7%99%D7%A9%D7%A8%D7%90%D7%9C ↩ ↩2
-
ICE, “ים המלח חוגג: תנופה אדירה לחברת הקוסמטיקה הישראלית,” 25 October 2023. https://www.ice.co.il/consumerism/news/article/985483 ↩ ↩2
-
Fosun, “Management Team,” biographies including December 2025 reference dates, accessed 30 September 2026. https://en.fosun.com/about/team.html ↩ ↩2 ↩3